|
TOP NEWS
POLICY & REGULATION
LITIGATION
Celgene Defends Dismissal Of Cancer Drug Antitrust Suit
By Danielle Ferguson
Bristol-Myers Squibb Co. and its subsidiary Celgene Corp. urged the Second Circuit to uphold the dismissal of health plans' proposed antitrust class action alleging that the drugmaker fraudulently obtained patents for the cancer drug Pomalyst, saying it properly disclosed materials to the patent office and filed valid patent infringement lawsuits against generic-drug makers.
Brief attached |
Read full article »
| Save to favorites »
Cannabis Event Founders Accused Of $750K Fraud
By Jonathan Capriel
A Los Angeles attorney and his business partner are accused in a California state lawsuit of diverting investor money to pay for private jet flights, bar dues and other personal expenses instead of funding business-to-consumer cannabis trade shows, including the failed 2022 Green Street Festival.
Complaint attached |
Read full article »
| Save to favorites »
EXPERT ANALYSIS
LEGAL INDUSTRY
Mich. Judge Weighs Toshiba Legal Bills Discovery Fight
By Melanie Dorsey
A Michigan federal judge on Wednesday questioned whether she needs to review specific objections to DTE Electric Co. and Consumers Energy Co.'s multimillion-dollar attorney fee request before deciding whether Toshiba Corp. must disclose its own legal bills and litigation expenses following a nearly $394.4 million jury verdict over a botched power plant overhaul.
Read full article »
| Save to favorites »
|